Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID

NCT06847191 is registered in ClinicalTrials.gov with BioVie Inc. as lead sponsor.

NCT NCT06847191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06847191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID
Lead sponsor
BioVie Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 29, 2025
Completion date
September 2, 2026
Enrollment
203 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

long covid